The Regents of the University of California is a clinical research site located in San Francisco, California, United States 94160.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
The Regents of the University of California has participated in 3 clinical trials with 2 currently active.
Therapeutic areas: Urothelial Carcinoma, Solid Tumors, Adult, Fibrodysplasia Ossificans Progressiva.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Nykode Therapeutics ASA, Ipsen.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Regents of the University of California has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Regents of the University of California has 3 clinical trials on record, with 2 currently active. Their work covers Urothelial Carcinoma, Solid Tumors, Adult, Fibrodysplasia Ossificans Progressiva.
The Regents of the University of California has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.